Neuromodulation for ADHD
Learning Objectives:
- Review of ADHD
- To understand the condition
- To explore the current pharmacologic and psychotherapeutic approaches
- Neuromodulation for ADHD: in the pipeline and FDA-cleared
- tDCS
- TMS
- eTNS
- Q & A
Date of Release: Friday, January 7, 2022
Date of Expiration: January 6, 2024
Format: ON-DEMAND
Cost: Members: $25 | Non-members $50 | Student Members FREE
SPEAKER:
Ian Cook, MD, DFAPA
Dr. Cook is a Director of the Los Angeles TMS Institute, Inc., and Professor Emeritus of Psychiatry and Biobehavioral Sciences in UCLA’s David Geffen School of Medicine, where he previously held the Miller Family Endowed Chair in Depression Research, was Director of the UCLA Depression Research & Clinic Program, and was the Founding Director of the UCLA TMS Service. Dr. Cook earned his bachelors degree with high honors from Princeton University and his medical degree from the Yale University School of Medicine. He completed his psychiatry residency training at UCLA's Neuropsychiatric Institute, where he also was an NIMH-funded research fellow, before joining the faculty. Dr. Cook served on the Executive Committee on Practice Guidelines of the American Psychiatric Association and guided the electronic dissemination of their evidence-based guidelines in psychiatry. A board-certified Psychiatrist, he has also served as an examiner for the American Board of Psychiatry and Neurology. His biography is profiled in Who's Who in America, Who's Who in the World, and Best Doctors. He is the author of numerous publications on brain function in mental illness and in aging and holds several dozen patents on biomedical devices and methods.